Syntheses of Enantiomerically Pure ent-Multifidene and Related Compounds

DOI: 10.1039/c39930000551

Source and publish data:

Journal of the Chemical Society. Chemical communications p. 551 - 552 (1993)

Update date:2022-07-29

Topics:

Authors:

Kramp, Peter

Helmchen, Guenter

Holmes, Andrew B.

Read Full Text PDF DownLoad Join now for total 90,000,000 free articles

Article abstract of DOI:10.1039/c39930000551

Enantiomers of multifidene and related compounds were synthesized from (1R)-7-syn-carboxy-2-norbornanone via Norrish Type I cleavage.

Full text of DOI:10.1039/c39930000551

View Article Online / Journal Homepage / Table of Contents for this issue

View Article Online

Products guided by the article

Product name:(1R,4R,7S)-2-Oxo-bicyclo[2.2.1]heptane-7-carbonyl chloride

Cas No:1064668-18-3

R&D Labs maybe for 1064668-18-3

Suzhou HeChuang Chemical Co.,Ltd.

Contact:+86-512-88800520

Address:No.9 Guanchao Rd,Changshu Advanced Materials Industy Park
Shanghai Synmedia Chemical Co., Ltd

Contact:+86-21-38681880

Address:6th Floor, 11A Building, No.528 Ruiqing Road, Heqing town, Pudong new district, Shanghai China
Lian Xing Chemical Co.,Ltd.

Contact:0792-8228321

Address:10TH Floor No.121 binjiang Road Xunyang District
Shanghai Xinda Pharmaceuticals Co., Ltd.

Contact:86-21-33692333-8008

Address:999 Linxian Road, Jinshan Industrial Park, Shanghai, China
Chongqing Werlchem Fine Chemical Co. Ltd

Contact:+86-23-67521957

Address:NO.15,Fortune Road,Yubei District,401121,Chongqing,China

Relevant to this article

Doi:10.1039/jr9530000093
(1953)
Metabolism of intravenous methylnaltrexone in mice, rats, dogs, and humans

Doi:10.1124/dmd.109.031179
(2010)
An efficient synthesis of bibenzylic oxygen heterocycles

Doi:10.3184/030823407X256091
(2007)
Gold(I)-catalyzed tandem reactions initiated by 1,2-indole migrations

Doi:10.1002/anie.200802660
(2008)
Doi:10.1021/jm00287a002
(1971)
Discovery of 5-(2-amino-[1,2,4]triazolo[1,5-a]pyridin-7-yl)-N-(tert-butyl) pyridine-3-sulfonamide (CZC24758), as a potent, orally bioavailable and selective inhibitor of PI3K for the treatment of inflammatory disease

Doi:10.1016/j.bmcl.2012.05.090
(2012)

Article Doi